Treatment of polypoidal choroidal vasculopathy by intravitreal injection of bevacizumab.
スポンサーリンク
概要
- 論文の詳細を見る
PURPOSE: To evaluate the efficacy of intravitreal bevacizumab (IVB) in eyes with polypoidal choroidal vasculopathy (PCV). METHODS: Seventeen eyes of 16 patients with either subfoveal or juxtafoveal PCV were treated with IVB. As the initial treatment, ten eyes were treated with a single injection of bevacizumab and seven were treated with three monthly injections. Additional IVB injections were performed in 15 eyes when either a recurrent or residual exudative change was seen. Follow-up after initiation of IVB ranged from 12 to 30 months (mean, 20.7 +/- 5.7 months). RESULTS: The mean foveal thickness before IVB (492 +/- 205 microm) decreased to 384 +/- 181 microm at 3 months (P = 0.0008), and with additional IVB for recurrent exudative changes, the foveal thickness remained significantly reduced at 12 months (392 +/- 203 microm, P = 0.0270). Mean visual acuity at baseline (0.54 +/- 0.38 in logMAR) somewhat improved to 0.45 +/- 0.32 at 3 months (P = 0.156). However, the improvement in visual acuity then subsided, and returned to the pretreatment value at 12 months (0.54 +/- 0.39). CONCLUSIONS: In eyes with PCV, IVB can reduce the exudative change and can maintain visual function for at least 1 year.
著者
関連論文
- Restoration of outer segments of foveal photoreceptors after resolution of central serous chorioretinopathy.
- 第103回 日本眼科学会総会 宿題報告II 眼内循環 網脈絡膜循環における白血球動態評価とその意義
- 増殖糖尿病網膜症における血管新生緑内障に対する線維柱帯切除術の成績
- 虚血網膜と眼循環
- 若年性脈絡膜新生血管に対する光線力学療法の2年成績
- 糖尿病症例に対する眼内レンズ移植術の長期予後
- Treatment of polypoidal choroidal vasculopathy by intravitreal injection of bevacizumab.
- 特発性黄斑円孔に対する硝子体手術 : 術後視力に影響する因子の解析
- Pars Plana Vitrectomy for Epiretinal Membrane Associated with Sarcoidosis
- Reproducibility of Scanning Laser Doppler Flowmetry in the Rat Retina and Optic Nervehead
- Polypoidal Choroidal Vasculopathy with Drusen
- Recurrence of Polypoidal Choroidal Vasculopathy After Photodynamic Therapy
- Treatment of polypoidal choroidal vasculopathy by intravitreal injection of bevacizumab.
- Macular Hole Formation Following Photodynamic Therapy Combined with Intravitreal Injection of Bevacizumab and Triamcinolone Acetonide
- Restoration of outer segments of foveal photoreceptors after resolution of central serous chorioretinopathy.
- Determinants of Patient Satisfaction with Photodynamic Therapy for Neovascular Age-related Macular Degeneration or Polypoidal Choroidal Vasculopathy
- Haplotype Analysis of the ARMS2/HTRA1 Region in Japanese Patients with Typical Neovascular Age-Related Macular Degeneration or Polypoidal Choroidal Vasculopathy
- VEGF gene polymorphism and response to intravitreal bevacizumab and triple therapy in age-related macular degeneration